Use of DMPC and DSPC lipids for verapamil and naproxen permeability studies by PAMPA

References

• Kansy M, Senner F, Gubernator K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem 1998;41:1007–10
   PubMed Web of Science ®Google Scholar
• Balimane PV, Pace E, Chong S, et al. A novel high-throughput automated chip-based nanoelectrospray tandem mass spectrometric method for PAMPA sample analysis. J Pharm Biomed Anal 2005;39:8–16
   PubMed Web of Science ®Google Scholar
• Fujikawa M, Ano R, Nakao K, et al. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability. Bioorg Med Chem 2005;13:4721–32
   PubMed Web of Science ®Google Scholar
• Sugano K, Hamada H, Machida M, et al. Optimized conditions of bio-mimetic artificial membrane permeation assay. Int J Pharm 2001;228:181–8
   PubMed Web of Science ®Google Scholar
• Sugano K, Nabuchi Y, Machida M, Aso Y. Prediction of human intestinal permeability using artificial membrane permeability. Int J Pharm 2003;257:245–51
   PubMed Web of Science ®Google Scholar
• Kerns EH, Di L, Petusky S, et al. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery. J Pharm Sci 2004;93:1440–53
   PubMed Web of Science ®Google Scholar
• Bermejo M, Avdeef A, Ruiz A, et al. PAMPA—a drug absorption in vitro model: 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones. Eur J Pharm Sci 2004;21:429–41
   PubMed Web of Science ®Google Scholar
• Liu H, Sabus C, Carter GT, et al. In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography/mass spectrometry detection. Pharm Res 2003;20:1820–6
   PubMed Web of Science ®Google Scholar
• Flaten GE, Dhanikula AB, Luthman K, Brandl M. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion. Eur J Pharm Sci 2006;27:80–90
   PubMed Web of Science ®Google Scholar
• Avdeef A, Bendels S, Di L, et al. PAMPA—critical factors for better predictions of absorption. J Pharm Sci 2007;96:2893–909
   PubMed Web of Science ®Google Scholar
• Avdeef A, Tsinman O. PAMPA—a drug absorption in vitro model: 13. Chemical selectivity due to membrane hydrogen bonding: in combo comparisons of HDM-, DOPC-, and DS-PAMPA models. Eur J Pharm Sci 2006;28:43–50
   PubMed Web of Science ®Google Scholar
• Teksin Z, Seo P, Polli J. Comparison of drug permeabilities and BCS classification: three lipid-component PAMPA system method versus caco-2 monolayers. AAPS J 2010;12:238–41
   PubMed Web of Science ®Google Scholar
• Leidy C, Wolkers WF, Jørgensen K, et al. Lateral organization and domain formation in a two component lipid membrane system. Biophys J 2001;80:1819–28
   PubMed Web of Science ®Google Scholar
• Vaz WL, Melo EC, Thompson TE. Translational diffusion and fluid domain connectivity in a two-component, two phase phospholipid bilayer. Biophys J 1989;56:869–76
   PubMed Web of Science ®Google Scholar
• Sankaram MB, Marsh D, Thompson TE. Determination of fluid and gel domain sizes in two-component, two-phase lipid bilayers. An electron spin resonance spin label study. Biophys J 1992;63:340–9
   PubMed Web of Science ®Google Scholar
• Sugár IP, Thompson TE, Biltonen RL. Monte Carlo simulation of two-component bilayers: DMPC/DSPC mixtures. Biophys J 1999;76: 2099–110
   PubMed Web of Science ®Google Scholar
• Bagatolli LA, Gratton E. A correlation between lipid domain shape and binary phospholipid mixture composition in free standing bilayers: a two-photon fluorescence microscopy study. Biophys J 2000;79:434–47
   PubMed Web of Science ®Google Scholar
• Nielsen LK, Vishnyakov A, Jørgensen K, et al. Nanometre-scale structure of fluid lipid membranes. J Phys Condens Matter 2000;12:A309
   Web of Science ®Google Scholar
• Shimshick EJ, McConnell HM. Lateral phase separation in phospholipid membranes. Biochemistry 1973;12:2351–60
   PubMed Web of Science ®Google Scholar
• Foster MC, Yguerabide J. Partition of a fluorescentmolecule between liquid-crystalline and crystalline regions of membranes. J Membr Biol 1979;45:125–46
   Web of Science ®Google Scholar
• Silvius JR, del Giudice D, Lafleur M. Cholesterol at different bilayer concentrations can promote or antagonize lateral segregation of phospholipids of differing acyl chain length. Biochemistry 1996;35:15198–208
   PubMed Web of Science ®Google Scholar
• Ipsen JH, Karlstrom G, Mouritsen OG, et al. Phase equilibria in the phosphatidylcholine–cholesterol system. Biochim Biophys Acta 1987;905:162–72
   PubMed Web of Science ®Google Scholar
• Ahmed SN, Brown DA, London E. On the origin of sphingolipid/cholesterol-rich detergent-insoluble cell membranes: physiological concentrations of cholesterol and sphingolipid induce formation of a detergent-insoluble, liquid-ordered lipid phase in model membranes. Biochemistry 1997;36:10944–53
   PubMed Web of Science ®Google Scholar
• Matsuoka S, Murata M. Cholesterol markedly reduces ion permeability induced by membrane-bound amphotericin B. Biochim Biophys Acta 2002;1564:429–34
   PubMed Web of Science ®Google Scholar
• Barenholz Y. Cholesterol and other membrane active sterols: from membrane evolution to “rafts”. Prog Lipid Res 2002;41:1–5
   PubMed Web of Science ®Google Scholar
• Alvarez-Figueroa MJ, Araya-Silva I, Díaz-Tobar C. Iontophoretic transdermal delivery of haloperidol. Pharm Dev Technol 2006;11:371–5
   PubMed Web of Science ®Google Scholar
• Alvarez-Figueroa MJ, Pessoa-Mahana CD, González-Bustamante DA. Influence of lipophilia and of the vehicle used in the transdermal absorption of novel benzimidazole compounds with possible anti-HIV activity. Pharm Dev Technol 2008;13:127–33
   PubMed Web of Science ®Google Scholar
• Ruell JA, Tsinman KL, Avdeef A. PAMPA—a drug absorption in vitro model: 5. Unstirred water layer in iso-pH mapping assays and pKaflux—optimized design (pOD-PAMPA). Eur J Pharm Sci 2003;20:393–402
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3–26
   PubMed Web of Science ®Google Scholar
• Fischer H, Kansy M, Avdeef A, Senner F. Permeation of permanently positive charged molecules through artificial membranes—influence of physico-chemical properties. Eur J Pharm Sci 2007;31:32–42
   PubMed Web of Science ®Google Scholar
• Majumdar S, Duvvuri S, Mitra AK. Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development. Adv Drug Deliv Rev 2004;56:1437–52
   PubMed Web of Science ®Google Scholar
• Fiorini R, Gratton E, Curatola G. Effect of cholesterol on membrane microheterogeneity: a study using 1,6-diphenyl-1,3,5-hexatriene fluorescence lifetime distributions. Biochim Biophys Acta 1989;1006:198–202
   PubMed Web of Science ®Google Scholar
• Virtanen J, Ruonala M, Vauhkonen M, Somerharju P. Lateral organization of liquid-crystalline cholesterol-dimyristoylphosphatidylcholine bilayers. Evidence for domains with hexagonal and centered rectangular cholesterol superlattices. Biochemistry 1995;34:11568–81
   PubMed Web of Science ®Google Scholar
• Chong PL. Evidence for regular distribution of sterols in liquid crystalline phosphatidylcholine bilayers. Proc Natl Acad Sci USA 1994;91:10069–73
   PubMed Web of Science ®Google Scholar
• Soto-Arriaza MA, Olivares-Ortega C, Quina FH, et al. Effect of cholesterol content on the structural and dynamic membrane properties of DMPC/DSPC large unilamellar bilayers. Biochim Biophys Acta 2013;1828:2763–9
   PubMed Web of Science ®Google Scholar
• Aguilar LF, Pino JA, Soto-Arriaza MA, et al. Differential dynamic and structural behavior of lipid-cholesterol domains in model membranes. PLoS one 2012;7:e40254
   PubMed Web of Science ®Google Scholar
• Moffat AC, Osselton MD, Widdop B, Clarke EGC. Clarke’s analysis of drugs and poisons. Pharmaceutical Press; 2004
   Google Scholar
• Alvarez-Figueroa MJ, Pessoa-Mahana CD, Palavecino-González ME, et al. Evaluation of the membrane permeability (PAMPA and skin) of benzimidazoles with potential cannabinoid activity and their relation with the Biopharmaceutics Classification System (BCS). AAPS PharmSciTech 2011;12:573–8
   PubMed Web of Science ®Google Scholar